The China Securities Regulatory Commission has opened an investigation into Shenzhen Yahuilong Biotechnology Co., Ltd. over suspected misleading statements in a company announcement. The case relates to a disclosure made on 7 January 2026 concerning the signing of a strategic cooperation framework agreement. The regulator said it will handle the matter in accordance with the law following a comprehensive investigation.
China Securities Regulatory Commission 2026-02-06
China Securities Regulatory Commission opens investigation into Shenzhen Yahuilong Biotechnology over suspected misleading disclosure
The China Securities Regulatory Commission is investigating Shenzhen Yahuilong Biotechnology Co., Ltd. for suspected misleading statements in a January 7, 2026, disclosure about a strategic cooperation framework agreement. The regulator will proceed with legal action based on the investigation's findings.